Novartis AG (NVSEF) Stock Research, Analysis & News

Quick Analysis on Novartis AG (NVSEF) Stock as of January 28, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Novartis AG (NVSEF) Stock below)

Novartis AG (NVSEF) Stock Profile Summary

Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide. Its Pharmaceuticals division offers prescription medicines in various therapeutic areas, including cardiovascular and metabolism; oncology; neuroscience and ophthalmics; respiratory; integrated hospital care; and other additional products. The companys Vaccines and Diagnostics division provides preventive vaccines and diagnostic tools. This division sells influenza, meningococcal, pediatric, and traveler vaccines; and blood testing and molecular diagnostics to prevent the spread of infectious diseases. Its Sandoz division provides prescription medicines, as well as pharmaceutical and biotechnological active substances. This division offers active ingredients and finished dosage forms of medicines; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; and cytotoxic products, as well as provides biotech manufacturing services to other companies. The companys Consumer Health division consists of three business units: over-the-counter medicines (OTC), Animal Health, and CIBA Vision. OTC unit offers readily available consumer medicines. Animal Health unit provides veterinary products for farm and companion animals. CIBA Vision unit manufactures contact lenses and lens care products. It has strategic partnership with Lonza, a Swiss pharmaceuticals manufacturing company. The company was founded in 1895 and is headquartered in Basel, Switzerland.

Novartis AG (NVSEF) Stock Key Statistics Research and Analysis as of January 28, 2020

Mutual Funds with Novartis AG (NVSEF) Stock in its top 10 holdings

FundCategoryNVSEF Holding Percentage
American Beacon Intl Equity InstlForeign Large Value2.31%
American Century Intl Core Equity CForeign Large Blend1.69%
American Century NT Intl Gr InstlForeign Large Growth1.55%
American Funds Europacific Growth CForeign Large Growth2.07%

ETFs with Novartis AG (NVSEF) Stock in its top 10 holdings

Latest Market News on Novartis AG (NVSEF)

Click here to find the latest news on Novartis AG (NVSEF)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center